ARCHIVES

CPSC Relies On NCI Findings For New Policy

This article is from The Cancer Letter archive.

Vol. 04 No. 29 | July 21, 1978

Download PDF Visit The Full Archive

Related Articles

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

December 27, 2002

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985